DEE40 (EIEE40; OMIM 617065) is an autosomal recessive developmental and epileptic encephalopathy attributed to biallelic variants in GUF1, which encodes the nuclear genome-encoded mitochondrial translation elongation factor EF-4 (mtEF4), the eukaryotic homolog of bacterial LepA. The mechanism runs through mitochondrial protein synthesis rather than through an ion channel: mtEF4 is a fidelity factor that remobilizes stalled mitoribosomes and transiently inhibits elongation, and its disruption compromises assembly of the respiratory chain complexes whose core subunits are made inside the mitochondrion. The single reported family presented with isolated West syndrome — infantile spasms with hypsarrhythmia and developmental regression. The evidence base is deliberately small: one consanguineous family with three affected siblings (2016), a single additional GUF1 patient in a targeted gene-panel cohort (2023), and functional work in yeast, worm, and mouse rather than in human neural tissue. The final step from respiratory chain assembly failure to the epilepsy is proposed by the discovering authors and has not been measured in patients.
Ask a research question about Developmental And Epileptic Encephalopathy 40. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Developmental And Epileptic Encephalopathy 40
creation_date: "2026-09-05T19:12:28Z"
description: >-
DEE40 (EIEE40; OMIM 617065) is an autosomal recessive developmental and
epileptic encephalopathy attributed to biallelic variants in GUF1, which
encodes the nuclear genome-encoded mitochondrial translation elongation factor
EF-4 (mtEF4), the eukaryotic homolog of bacterial LepA. The mechanism runs
through mitochondrial protein synthesis rather than through an ion channel:
mtEF4 is a fidelity factor that remobilizes stalled mitoribosomes and
transiently inhibits elongation, and its disruption compromises assembly of
the respiratory chain complexes whose core subunits are made inside the
mitochondrion. The single reported family presented with isolated West
syndrome — infantile spasms with hypsarrhythmia and developmental regression.
The evidence base is deliberately small: one consanguineous family with three
affected siblings (2016), a single additional GUF1 patient in a targeted
gene-panel cohort (2023), and functional work in yeast, worm, and mouse rather
than in human neural tissue. The final step from respiratory chain assembly
failure to the epilepsy is proposed by the discovering authors and has not
been measured in patients.
category: Mendelian
parents:
- Genetic Developmental and Epileptic Encephalopathy
synonyms:
- DEE40
- EIEE40
- early infantile epileptic encephalopathy 40
- epileptic encephalopathy, early infantile, 40
- GUF1 early infantile epileptic encephalopathy
- early infantile epileptic encephalopathy caused by mutation in GUF1
disease_term:
preferred_term: developmental and epileptic encephalopathy, 40
term:
id: MONDO:0014895
label: developmental and epileptic encephalopathy, 40
inheritance:
- name: Autosomal recessive inheritance
description: >-
The reported family was consanguineous, and the three affected siblings were
homozygous for the same GUF1 missense variant (c.1825G>T, p.(Ala609Ser)).
Only one family has been reported with segregation data, so the recessive
mode rests on that single pedigree together with Orphanet's gene-disease
assertion.
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we exome-sequenced the members of a consanguineous family affected with isolated WS. We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
explanation: >-
Homozygosity for one variant in three affected siblings of a consanguineous
family is the segregation pattern that establishes recessive inheritance
here.
pathophysiology:
- name: Biallelic GUF1 Variants
biological_scale: MOLECULAR
role: trigger
description: >-
The initiating lesion is a homozygous GUF1 missense variant. In the reported
family the allele is c.1825G>T, p.(Ala609Ser), which substitutes an alanine
conserved across all eukaryotic organisms and positioned within the
tRNA-binding moiety of the protein. Note that the functional consequence is
reported as a modification of activity under suboptimal conditions rather
than as a clean null, so this node is deliberately not labelled a loss of
function.
genes:
- preferred_term: GUF1
term:
id: hgnc:25799
label: GUF1
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The variant identified in the WS family changes an alanine residue conserved in all eukaryotic organisms and positioned within the tRNA-binding moiety of this nuclear genome-encoded mitochondrial translational elongation factor."
explanation: >-
Locates the disease allele within the tRNA-binding region of mtEF4 and
establishes the residue's conservation, the basis for treating it as the
initiating lesion.
downstream:
- target: Impaired Mitochondrial Translation Elongation Fidelity
causal_link_type: DIRECT
description: >-
The variant alters mtEF4 activity in the conditions under which the factor
is required, as measured by yeast complementation.
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Yeast complementation assays show that the activity of GUF1(A609S) is modified in suboptimal environments."
explanation: >-
The functional assay linking the patient allele to altered elongation
factor activity, which is the next node.
- name: Impaired Mitochondrial Translation Elongation Fidelity
biological_scale: MOLECULAR
description: >-
GUF1/mtEF4 is a quality-control factor of mitochondrial protein synthesis
rather than a core elongation engine: it binds mitoribosomes in a
GTP-dependent manner, remobilizes stalled ribosomes, and transiently inhibits
elongation so that synthesis remains accurate. No modifier is asserted on the
elongation process below because the reported direction is
condition-dependent — yeast lacking Guf1 show diminished synthesis rates at
low temperature, whereas mouse mtEF4 deletion accelerates mitochondrial
translation at the cost of producing unstable proteins. What is consistent
across systems is the loss of fidelity, not a single direction of rate
change.
biological_processes:
- preferred_term: mitochondrial translational elongation
term:
id: GO:0070125
label: mitochondrial translational elongation
molecular_functions:
- preferred_term: GTPase activity
term:
id: GO:0003924
label: GTPase activity
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
evidence_source: OTHER
snippet: "GUF1 encodes a protein essential in conditions that counteract faithful protein synthesis: it is able to remobilize stuck ribosomes and transiently inhibit the elongation process to optimize protein synthesis."
explanation: >-
States the molecular role of the gene product that this node models.
Evidence source is OTHER because the sentence is background molecular
biology synthesised from model-system work, not a clinical observation
made in this study.
- reference: PMID:18442968
reference_title: The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The observed defects in Guf1-deficient mitochondria are consistent with a function of Guf1 as a fidelity factor of mitochondrial protein synthesis."
explanation: >-
Establishes the fidelity-factor role in the yeast ortholog, the conserved
function whose disruption this node describes.
- reference: PMID:18442968
reference_title: The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "It binds to mitochondrial ribosomes in a GTP-dependent manner."
explanation: >-
Supports the GTPase and ribosome-engagement molecular function annotated on
this node.
- reference: PMID:27065197
reference_title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Deletion of mtEF4 accelerated mitochondrial translation at the cost of producing unstable proteins."
explanation: >-
The mammalian in vivo result, and the reason this node asserts a fidelity
defect without asserting a direction of rate change: here loss of mtEF4
speeds translation up rather than slowing it.
downstream:
- target: Defective Respiratory Chain Complex Assembly
causal_link_type: DIRECT
description: >-
Because the mitochondrially translated polypeptides are the core subunits
of the respiratory chain complexes, infidelity in their synthesis yields
products that cannot be assembled into functional complexes.
evidence:
- reference: PMID:18442968
reference_title: The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "At elevated temperatures, Guf1-deficient mutants exhibit defects in the assembly of cytochrome oxidase, suggesting that the polypeptides produced are not functional."
explanation: >-
Directly connects the translation-fidelity defect to failed cytochrome
oxidase assembly, which is the causal step this edge asserts.
- name: Defective Respiratory Chain Complex Assembly
biological_scale: CELLULAR
role: central_effector
description: >-
Loss of mtEF4 function impairs biogenesis of the oxidative phosphorylation
complexes, with complex IV the most consistently affected across model
systems: cytochrome oxidase assembly fails in Guf1-deficient yeast at
restrictive temperature, respiratory chain supercomplexes containing complex
IV are disrupted in mtef4-null C. elegans at low temperature, and knockout of
mtEF4 in human cells induces respiratory chain complex defects and apoptosis.
This node is the mechanistic pivot the discovering authors proposed for the
epilepsy, and it is supported entirely by non-human or non-neural systems —
no respiratory chain measurement has been reported in a DEE40 patient.
biological_processes:
- preferred_term: mitochondrial respiratory chain complex assembly
term:
id: GO:0033108
label: mitochondrial respiratory chain complex assembly
modifier: DECREASED
evidence:
- reference: PMID:24837196
reference_title: Mitochondrial EF4 links respiratory dysfunction and cytoplasmic translation in Caenorhabditis elegans.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "At low temperature (15°C), mtef4 deletion reduces mitochondrial translation and disrupts the assembly of respiratory chain supercomplexes containing complex IV."
explanation: >-
A whole-organism metazoan result tying mtEF4 loss to disrupted complex IV
supercomplex assembly.
- reference: PMID:29572227
reference_title: Human Elongation Factor 4 Regulates Cancer Bioenergetics by Acting as a Mitochondrial Translation Switch.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Knockout of mtEF4 induced respiratory chain complex defects and apoptosis, while its overexpression stimulated cancer development."
explanation: >-
Shows the same consequence for the human protein in cultured cells. Cited
only for the respiratory chain phenotype of mtEF4 loss; the tumour biology
that is this paper's subject is not relevant to DEE40.
- reference: PMID:30693836
reference_title: Mitochondrial translation factor EF4 regulates oxidative phosphorylation complexes and the production of ROS.
supports: SUPPORT
evidence_source: OTHER
snippet: "We will discuss the influence of mtEF4 on the electron transport chain, especially at respiratory chain complex IV, which could result in cytochrome c peroxidase formation, electron leakage from electron transport chain and ROS increase."
explanation: >-
A review summarising the complex IV focus of the mtEF4 respiratory
phenotype and the proposed ROS consequence. Evidence source is OTHER
because this is a review, and the ROS arm is stated as a possibility
("could result in"), so it is not asserted as a node here.
downstream:
- target: Neuronal Energy Failure and Epileptic Encephalopathy
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
The step from respiratory chain assembly failure to infantile spasms is the
link the discovering authors proposed, by analogy with the broader
association between respiratory chain defects and infantile epilepsy. The
intervening events in developing human neurons have not been demonstrated.
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "We suggest a new link between improper assembly of respiratory chain complexes and WS."
explanation: >-
Classified INDIRECT because the authors offer this as a suggested link
rather than a demonstrated mechanism; no patient respiratory chain or
neuronal measurement is reported.
- name: Neuronal Energy Failure and Epileptic Encephalopathy
biological_scale: ORGANISM
role: consequence
description: >-
The clinical endpoint is an early-infantile developmental and epileptic
encephalopathy presenting as West syndrome. The energy-failure framing is
inherited from the general association between respiratory chain disorders
and infantile epilepsy rather than from any measurement in GUF1 patients,
which is why this node carries no biological process annotation asserting a
bioenergetic deficit in human neural tissue.
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "To get better insights on the genetic of this pathology, we exome-sequenced the members of a consanguineous family affected with isolated WS."
explanation: >-
Establishes that the affected siblings' clinical endpoint was isolated West
syndrome, the phenotype this consequence node represents.
phenotypes:
- name: Infantile spasms
category: Neurologic
description: >-
The reported siblings had isolated West syndrome, of which infantile spasms
are the defining seizure type. Orphanet independently lists GUF1 as a
disease-causing gene for infantile epileptic spasms syndrome.
phenotype_term:
preferred_term: Infantile spasms
term:
id: HP:0012469
label: Infantile spasms
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
explanation: >-
Classified INDIRECT: the paper states the siblings had isolated West
syndrome and separately defines that syndrome by this triad, so the spasms
follow from the diagnosis rather than from a per-patient description. The
accessible record for this paper does not include the case narratives.
- reference: ORPHA:697160
reference_title: Infantile epileptic spasms syndrome
supports: SUPPORT
evidence_source: OTHER
snippet: "GUF1 | GTP binding elongation factor GUF1 | hgnc:25799 | Disease-causing germline mutation(s) in"
explanation: >-
Orphanet's gene-disease row placing GUF1 among the causes of infantile
epileptic spasms syndrome, independent of the primary report.
- name: Hypsarrhythmia
category: Neurologic
description: >-
Hypsarrhythmia is the pathognomonic interictal EEG pattern of West syndrome,
the diagnosis carried by the reported siblings.
phenotype_term:
preferred_term: Hypsarrhythmia
term:
id: HP:0002521
label: Hypsarrhythmia
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
explanation: >-
Classified INDIRECT for the same reason as the spasms phenotype: the EEG
pattern follows from the stated West syndrome diagnosis rather than from a
reported per-patient EEG in the accessible record.
- name: Developmental regression
category: Neurologic
description: >-
Loss of acquired developmental skills is the third element of the West
syndrome triad by which the affected siblings were characterised.
phenotype_term:
preferred_term: Developmental regression
term:
id: HP:0002376
label: Developmental regression
clinical_course: PROGRESSIVE
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
explanation: >-
Classified INDIRECT: regression follows from the West syndrome diagnosis
applied to these siblings rather than from an individual case description.
- name: Global developmental delay
category: Neurologic
description: >-
A further GUF1 patient was ascertained in a paediatric cohort whose entry
criterion was refractory epilepsy together with global developmental delay.
The delay is therefore established for that patient by cohort membership.
phenotype_term:
preferred_term: Global developmental delay
term:
id: HP:0001263
label: Global developmental delay
evidence:
- reference: PMID:37820178
reference_title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "In this retrospective cohort study, patients with refractory epilepsy and global developmental delay, defined as epileptic encephalopathy, who applied to the Aydın 7Maternity and Children's Hospital Genetic Diagnosis Center and were followed in the pediatric neurology clinic of our hospital, between July 2018 and July 2021, were included."
explanation: >-
Classified INDIRECT: this is the cohort inclusion criterion, and a GUF1
patient was among those enrolled, so the delay is inferred from cohort
membership rather than reported individually.
- name: Refractory epilepsy
category: Neurologic
description: >-
The same cohort required drug-resistant epilepsy for enrolment, so the
reported GUF1 patient's epilepsy was refractory.
phenotype_term:
preferred_term: Refractory epilepsy
term:
id: HP:0020174
label: Refractory drug response
evidence:
- reference: PMID:37820178
reference_title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "Targeted next-generation sequencing molecular genetics results were reviewed, and 3 ALDH7A1, 1 AARS, 3 CACNA1A, 1 CTNNB1, 1 DCX, 2 DBH, 2 DOCK7, 1 FOLR1, 2 GABRB3, 2 GCH1, 1 VGRIN2B, 1 GUF1, 3 KCNQ2, 2 KCNT1, 1 NECAP1, 1 PCDH19, 1 PNPO, 1 SCN8A, 1 SCN9A, 4 SCN1A, 2 SLC25A22, 1 SLC2A1, 2 SPTAN1, 2 SZT2, 4 TBC1D24, 2 TH, and 1 PCDH19 (X chromosome) mutations were detected in three of the patients using the next-generation sequencing method."
explanation: >-
Classified INDIRECT: documents that a GUF1 patient was among those
genotyped in a cohort defined by refractory epilepsy, establishing the
drug-resistance by enrolment criterion rather than by individual report.
genetic:
- name: GUF1
gene_term:
preferred_term: GUF1
term:
id: hgnc:25799
label: GUF1
association: Pathogenic Variants
relationship_type: CAUSATIVE
notes: >-
GUF1 (GTP binding elongation factor GUF1) is the only gene implicated in
DEE40 (MONDO:0014895; OMIM 617065). The single reported segregating allele is
the homozygous missense c.1825G>T, p.(Ala609Ser), found in three affected
siblings of one consanguineous family by exome sequencing. A second,
unspecified GUF1 variant was reported in one patient of a 198-patient
targeted-panel cohort. The gene-disease relationship therefore rests on a
single multiplex pedigree plus a supportive functional assay, and Orphanet
lists GUF1 among the disease-causing genes for infantile epileptic spasms
syndrome. External gene-disease validity curation reflects the same thin
base: Genomics England PanelApp lists GUF1 at AMBER (confidence level 2) on
its early onset or syndromic epilepsy panel, and at RED (level 1) on its
mitochondrial disorders panel (PanelApp API, checked 2026-09-06; recorded as
prose because PanelApp is not a snippet-citable structured source in this
repository). No functional_impact_category is asserted: the yeast assay
reports that the variant's activity is "modified in suboptimal environments"
rather than abolished, which does not license a loss-of-function call.
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
explanation: >-
The variant-level gene-disease observation on which the entry rests.
- reference: ORPHA:697160
reference_title: Infantile epileptic spasms syndrome
supports: SUPPORT
evidence_source: OTHER
snippet: "GUF1 | GTP binding elongation factor GUF1 | hgnc:25799 | Disease-causing germline mutation(s) in"
explanation: >-
Orphanet's curated gene-disease assertion for GUF1, corroborating the
causative relationship recorded here.
- reference: PMID:37820178
reference_title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "An identifiable underlying genetic cause was identified in 48 (25%) out of 198 patients."
explanation: >-
Establishes the diagnostic-yield context of the panel cohort in which one
further GUF1 patient was identified.
prevalence:
- population: Worldwide
measure_type: CASES_IN_LITERATURE
prevalence_class: ULTRA_RARE
notes: >-
DEE40 is ultra-rare and has no estimated population prevalence. The reported
literature amounts to three affected siblings in one consanguineous family
(2016) and one further patient carrying a GUF1 variant in a 198-patient
targeted next-generation sequencing cohort (2023) — four patients in total by
that count, which is a dated lower bound rather than a current total. The
1:3500 figure quoted in the primary report is the birth incidence of West
syndrome from all causes, not of GUF1-related disease, and must not be read
as a DEE40 rate.
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
explanation: >-
The three-sibling count from the index family, kept as a literature case
count rather than converted to a population rate.
diagnosis:
- name: Electroencephalography
description: >-
EEG demonstrating hypsarrhythmia is what establishes the West syndrome
presentation through which DEE40 has come to clinical attention; the pattern
is pathognomonic for the syndrome. Etiologic diagnosis then requires
sequencing.
diagnosis_term:
preferred_term: electroencephalography
term:
id: NCIT:C38054
label: Electroencephalography
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
explanation: >-
The paper calls hypsarrhythmia pathognomonic of the syndrome the siblings
carried, and hypsarrhythmia is an EEG finding, which is what makes EEG the
presentation-defining test. Classified INDIRECT because the sentence is
definitional rather than a report of the patients' own EEG recordings.
- name: Brain magnetic resonance imaging
description: >-
Cranial imaging is performed to exclude a structural cause for the seizures
rather than to identify a DEE40-specific lesion. In the panel cohort that
ascertained a GUF1 patient, imaging was done in every patient and found no
structural anomaly capable of causing the seizures — an exclusionary result.
No DEE40-specific neuroimaging finding has been described.
diagnosis_term:
preferred_term: brain magnetic resonance imaging
term:
id: NCIT:C16809
label: Magnetic Resonance Imaging
evidence:
- reference: PMID:37820178
reference_title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "Cranial imaging was performed in all patients. There was no structural anomaly that could cause a seizure."
explanation: >-
Establishes imaging as a routine exclusionary step in the cohort that
included a GUF1 patient. Classified INDIRECT because the finding is
reported for the whole 198-patient cohort rather than for the GUF1 patient
individually.
- name: Whole exome sequencing
description: >-
GUF1 was identified as the candidate gene by exome sequencing of a
consanguineous multiplex family, and exome or genome sequencing remains the
route to a DEE40 diagnosis.
diagnosis_term:
preferred_term: whole exome sequencing
term:
id: NCIT:C101295
label: Whole Exome Sequencing
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we exome-sequenced the members of a consanguineous family affected with isolated WS"
explanation: >-
Establishes exome sequencing as the method that produced the diagnosis.
- name: Targeted next-generation sequencing epilepsy panel
description: >-
GUF1 is included on targeted epilepsy gene panels, which is how the one
further reported patient was ascertained.
diagnosis_term:
preferred_term: targeted next-generation sequencing gene panel
term:
id: NCIT:C198412
label: Multi-gene Panel Sequencing
evidence:
- reference: PMID:37820178
reference_title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Targeted next-generation sequencing molecular genetics results were reviewed"
explanation: >-
Documents the targeted panel as the diagnostic modality in the cohort that
identified a GUF1 patient.
treatments:
- name: Genetic counseling
description: >-
Because DEE40 is autosomal recessive and the reported family was
consanguineous, recurrence-risk counselling and carrier testing are part of
family care. No disease-modifying or GUF1-specific therapy exists, and no
antiseizure drug response has been reported in a GUF1 patient (see notes).
treatment_term:
preferred_term: genetic counseling
term:
id: NCIT:C15240
label: Genetic Counseling
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we exome-sequenced the members of a consanguineous family affected with isolated WS. We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
explanation: >-
Establishes the consanguineous, biallelic recurrence situation that makes
recurrence-risk counselling relevant.
animal_models:
- name: mtEF4 knockout mouse
species: Mouse
genotype: mtEF4 (Guf1) knockout, including germline-specific conditional deletion
category: Genetic
publication: PMID:27065197
description: >-
Whole-animal and germline-specific mtEF4 knockout mice were made to test the
physiological requirement for the factor. The result is informative for the
translation node of this entry and, equally importantly, is a negative result
for the neurological one: the phenotype is testis-restricted male infertility,
with somatic tissues compensating through mTOR-driven cytoplasmic
translation. No epilepsy or encephalopathy phenotype is reported.
modeled_mechanisms:
- target: Impaired Mitochondrial Translation Elongation Fidelity
relationship: RECAPITULATES
fidelity: MODERATE
model_scale: ORGANISM
description: >-
Deleting mtEF4 in the mouse produces exactly the fidelity defect this node
models — mitochondrial translation runs faster and yields unstable
proteins — giving the node a mammalian in vivo measurement.
limitations: >-
A complete knockout models null activity, whereas the human allele is a
missense variant whose activity is altered rather than abolished, so the
severity is not matched. The direction of the rate change is also opposite
to that seen in cold-stressed yeast, so this model fixes the fidelity claim
but not a direction of translational rate change.
evidence:
- reference: PMID:27065197
reference_title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Deletion of mtEF4 accelerated mitochondrial translation at the cost of producing unstable proteins."
explanation: >-
Supports treating the knockout mouse as informative for the
translation-fidelity node.
- target: Neuronal Energy Failure and Epileptic Encephalopathy
relationship: FAILS_TO_RECAPITULATE
fidelity: LOW
model_scale: ORGANISM
description: >-
The mouse knockout does not reproduce the human neurological endpoint. The
reported consequence of mtEF4 ablation is testis-specific oxidative
phosphorylation dysfunction causing male infertility; somatic tissues,
which include the brain, compensate by upregulating mTOR-driven cytoplasmic
translation to match the accelerated mitochondrial rate.
limitations: >-
This is a reported absence of a neurological phenotype in a study designed
around fertility, not a dedicated neurological or EEG assessment, so it is
weaker than a deliberate negative finding. The compensation mechanism was
characterised in somatic tissue generally rather than in neurons
specifically, and mouse and human may differ in the developmental window
over which such compensation is available.
evidence:
- reference: PMID:27065197
reference_title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
supports: REFUTE
evidence_source: MODEL_ORGANISM
snippet: "Here we report that genetic ablation of mitochondrial EF4 (mtEF4) in mice causes testis-specific dysfunction in oxidative phosphorylation, leading to male infertility."
explanation: >-
The phenotype of mtEF4 ablation in the mouse is testis-specific and does
not include the encephalopathy this node models, which refutes the mouse
as a model of the human neurological endpoint.
- reference: PMID:27065197
reference_title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Somatic tissues overcame this defect by activating mechanistic (mammalian) target of rapamycin (mTOR), thereby increasing rates of cytoplasmic translation to match rates of mitochondrial translation."
explanation: >-
Gives the mechanism by which somatic tissues escape the defect, which is
the proposed explanation for why the mouse spares the nervous system.
- name: mtef4-null Caenorhabditis elegans
species: Caenorhabditis elegans
genotype: mtef4 (C. elegans mtEF4 ortholog) deletion
category: Genetic
publication: PMID:24837196
description: >-
Deleting the C. elegans mtEF4 ortholog produces mitochondrial dysfunction,
growth delay and reduced brood size at normal temperature, and at low
temperature reduces mitochondrial translation and disrupts complex
IV-containing respiratory chain supercomplexes. It is the model that connects
the translation defect to respiratory chain assembly in a whole metazoan.
modeled_mechanisms:
- target: Defective Respiratory Chain Complex Assembly
relationship: RECAPITULATES
fidelity: MODERATE
model_scale: ORGANISM
description: >-
Loss of mtEF4 in the worm disrupts assembly of respiratory chain
supercomplexes containing complex IV, the assembly failure this node
models.
limitations: >-
The supercomplex disruption is observed at 15°C rather than at the animal's
optimal temperature, so it is a cold-stress phenotype and may overstate what
happens at mammalian body temperature. C. elegans has no nervous system
comparable to the developing human cortex, so the model speaks to the
assembly node only and not to the neurological consequence.
evidence:
- reference: PMID:24837196
reference_title: Mitochondrial EF4 links respiratory dysfunction and cytoplasmic translation in Caenorhabditis elegans.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "At low temperature (15°C), mtef4 deletion reduces mitochondrial translation and disrupts the assembly of respiratory chain supercomplexes containing complex IV."
explanation: >-
Supports treating the worm deletion as informative for the respiratory
chain assembly node.
evidence:
- reference: PMID:24837196
reference_title: Mitochondrial EF4 links respiratory dysfunction and cytoplasmic translation in Caenorhabditis elegans.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "At worms' optimum growing temperature (20°C), mtef4 deletion leads to self-brood size reduction, growth delay and mitochondrial dysfunction."
explanation: >-
Establishes that the deletion causes mitochondrial dysfunction in this
organism even without cold stress.
experimental_models:
- name: Yeast guf1-null complementation assay
description: >-
Saccharomyces cerevisiae lacking GUF1 has cold- and heat-sensitive growth
defects on non-fermentable carbon sources and defective cytochrome oxidase
assembly. Complementing that strain with human GUF1 alleles grades their
function, and this is the assay that supplied the only functional evidence for
the patient variant.
experimental_model_type: OTHER
organism:
preferred_term: Saccharomyces cerevisiae
term:
id: NCBITaxon:4932
label: Saccharomyces cerevisiae
publication: PMID:26486472
modeled_mechanisms:
- target: Impaired Mitochondrial Translation Elongation Fidelity
relationship: MEASURES
fidelity: MODERATE
model_scale: CELLULAR
description: >-
The complementation assay reads out how well a given GUF1 allele supports
mitochondrial protein synthesis under the suboptimal conditions in which
the factor is required, which is the functional grading behind the
pathogenicity claim.
limitations: >-
A yeast growth readout is several steps removed from a human neuronal
phenotype, and the reported effect is a modification of activity under
suboptimal conditions rather than a clear-cut loss, so the assay
establishes that the variant is functionally consequential without
quantifying how consequential it is for human brain development.
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Yeast complementation assays show that the activity of GUF1(A609S) is modified in suboptimal environments."
explanation: >-
The assay result grading the patient allele, which is the measurement
this model contributes.
evidence:
- reference: PMID:18442968
reference_title: The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Mutants lacking Guf1 show cold- and heat-sensitive growth defects on non-fermentable carbon sources that are especially pronounced under nutrient-limiting conditions."
explanation: >-
Characterises the yeast null phenotype that makes the complementation
readout interpretable.
discussions:
- discussion_id: gap_human_neuronal_bioenergetics
kind: KNOWLEDGE_GAP
status: OPEN
prompt: >-
Do DEE40 patients actually have a measurable respiratory chain or
bioenergetic deficit, and is it present in neural tissue?
attaches_to:
- "pathophysiology#Defective Respiratory Chain Complex Assembly"
- "pathophysiology#Neuronal Energy Failure and Epileptic Encephalopathy"
rationale: >-
Every respiratory chain observation supporting this entry comes from yeast,
worm, or cultured human cancer cells. No muscle or fibroblast respiratory
chain enzymology, lactate, or oxidative phosphorylation measurement has been
published for a GUF1 patient, and the discovering authors present the link to
West syndrome as a suggestion. Until such a measurement exists, the central
effector node of this entry is supported only by cross-species inference,
which is also why no conformance to a mitochondrial mechanism module is
declared (see notes).
proposed_experiments:
- experiment_id: exp_guf1_patient_respiratory_chain
name: Respiratory chain assessment in GUF1 patient-derived cells
description: >-
Measure respiratory chain complex activities, assembly by blue-native
electrophoresis, and mitochondrial translation rates in fibroblasts or
iPSC-derived neurons from a GUF1 p.(Ala609Ser) homozygote against controls,
to establish whether the assembly defect seen in model systems is present
in patient cells and whether it is neuron-selective.
evidence:
- reference: PMID:26486472
reference_title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
supports: SUPPORT
directness: INDIRECT
evidence_source: HUMAN_CLINICAL
snippet: "We suggest a new link between improper assembly of respiratory chain complexes and WS."
explanation: >-
The authors' own framing of the mechanism as a suggestion is what this gap
records. Classified INDIRECT because it evidences the state of the argument
rather than a measurement.
- discussion_id: gap_mouse_spares_nervous_system
kind: HUMAN_MODEL_MISMATCH
status: OPEN
prompt: >-
Why does mtEF4 knockout in the mouse produce testis-restricted disease while
the human variant produces an epileptic encephalopathy with no reported
fertility phenotype?
attaches_to:
- "pathophysiology#Neuronal Energy Failure and Epileptic Encephalopathy"
- "animal_models#mtEF4 knockout mouse"
rationale: >-
This is a mismatch rather than an absence of evidence: the mouse knockout was
made and characterised, and its phenotype is male infertility from
testis-specific oxidative phosphorylation failure, with somatic tissues
compensating through mTOR-driven cytoplasmic translation. The organ affected
in the mouse is not the organ affected in the reported human family. Either
the developing human brain cannot mount the somatic compensation that mouse
somatic tissues can, or the human missense allele acts differently from a
null, or the mouse neurological phenotype was simply not looked for. The
distinction matters because the mouse is currently the only mammalian in vivo
system available for this gene, and reading it as a model of DEE40 would
misstate what has been shown.
proposed_experiments:
- experiment_id: exp_neuro_phenotyping_mtef4_mouse
name: Neurological phenotyping of mtEF4-deficient mice
description: >-
Perform EEG, seizure-susceptibility and developmental assessment in
constitutive and neuron-specific mtEF4 knockout mice, and measure mTOR
pathway activity and cytoplasmic translation rates in brain, to test
whether the nervous system is genuinely spared or merely unexamined, and
whether neuronal compensation differs from that in other somatic tissues.
- experiment_id: exp_knockin_a609s_mouse
name: Knock-in of the patient allele
description: >-
Generate a mouse carrying the orthologous p.(Ala609Ser) substitution rather
than a null allele, to test whether the human missense variant produces a
neurological phenotype that complete ablation does not.
evidence:
- reference: PMID:27065197
reference_title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Here we report that genetic ablation of mitochondrial EF4 (mtEF4) in mice causes testis-specific dysfunction in oxidative phosphorylation, leading to male infertility."
explanation: >-
Documents the tissue specificity of the mouse phenotype, which is the
mismatch with the human presentation that this discussion records.
notes: >-
Scale of the evidence. This entry is deliberately shallow because the
literature is. Human evidence for DEE40 consists of one consanguineous family
with three affected siblings (PMID:26486472) and one further GUF1 patient
counted in a targeted-panel cohort (PMID:37820178). Everything mechanistic
comes from yeast, C. elegans, mouse, or cultured human cancer cells. Phenotypes
are curated only where the cached source supports them: the accessible record
for the primary paper carries the abstract and reference list but not the case
narratives, so features that would be expected in an early infantile
encephalopathy — microcephaly, hypotonia, specific neuroimaging findings — are
deliberately absent rather than assumed. The three West syndrome triad
phenotypes are marked directness INDIRECT because they follow from the stated
syndrome diagnosis rather than from per-patient description.
Deliberate non-conformances. No conforms_to is declared, and two candidate
modules were considered and rejected. The mitochondrial_dysfunction module
scopes itself to the aging hallmark and expects its central effector node to
carry decreased oxidative phosphorylation and increased reactive oxygen species;
neither has been measured in a GUF1 patient, and the ROS arm is stated as a
possibility even in the mtEF4 review (PMID:30693836). The
complex_iv_assembly_deficiency module models isolated cytochrome c oxidase
deficiency as a human biochemical diagnosis, and no COX enzymology exists for
any DEE40 patient; the complex IV signal here is entirely from yeast and worm.
Declaring either conformance would assert measurements that have not been made
(see gap_human_neuronal_bioenergetics). This should be revisited if patient
respiratory chain data are published.
No antiseizure treatment is curated. Neither human report describes the
seizure response of a GUF1 patient to any specific drug. The 2023 cohort paper
discusses antiseizure regimens in two places, and neither licenses a DEE40
treatment entry. Its Dravet syndrome passage names agents for a different
patient with a different gene, so attributing those to DEE40 would be
named-entity confusion. Its West syndrome passage reports that the risk of
developing Lennox-Gastaut syndrome was lower in patients who received a
ketogenic diet, prednisone, or ACTH — but that is a cohort-level association
in mixed-etiology West syndrome, made while recounting a 98-patient follow-up
study, reported for LGS risk rather than for seizure response, and the paper
never states that its GUF1 patient was among its four West syndrome patients.
Curating those agents here would attribute a population-level
infantile-spasms observation to a four-patient disease that no source
connects them to. Only genetic counselling is curated, which the recessive
consanguineous pedigree supports directly.
Prevalence caveat. The 1:3500 live-birth figure in the primary report is the
incidence of West syndrome from all causes and is recorded in the prevalence
notes explicitly as not a DEE40 rate.
references:
- reference: PMID:26486472
title: West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1.
- reference: PMID:37820178
title: Importance of targeted next-generation sequencing in pediatric patients with developmental epileptic encephalopathy.
- reference: PMID:18442968
title: The membrane-bound GTPase Guf1 promotes mitochondrial protein synthesis under suboptimal conditions.
- reference: PMID:27065197
title: Mammalian elongation factor 4 regulates mitochondrial translation essential for spermatogenesis.
- reference: PMID:24837196
title: Mitochondrial EF4 links respiratory dysfunction and cytoplasmic translation in Caenorhabditis elegans.
- reference: PMID:29572227
title: Human Elongation Factor 4 Regulates Cancer Bioenergetics by Acting as a Mitochondrial Translation Switch.
- reference: PMID:30693836
title: Mitochondrial translation factor EF4 regulates oxidative phosphorylation complexes and the production of ROS.
- reference: ORPHA:697160
title: Infantile epileptic spasms syndrome
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Create: developmental and epileptic encephalopathy, 40 · 2026-09-06T00:34:23Z · View source
De novo curation of DEE40 (MONDO:0014895), the first GUF1 (hgnc:25799) entry in the KB and a mitochondrial-translation DEE distinct from the ion-channel DEEs. Claim issue 11070. Deep research: falcon (Edison) was requested but returned HTTP 402 (account out of credits) on every attempt; the run used the repository fallback mechanism (just dr_fallback='--fallback') and was produced by claude_code, with fell_back/requested_provider/provider_attempts stamped in the report frontmatter. Report reference validation: 13/13 identifiers verified, 14/14 quotes valid; preflight-dr PASS against MONDO:0014895 (GUF1=58 mentions, OMIM 617065 matches; mondo_id passed manually per issue 10335). Entry: 4-node pathophysiology chain (biallelic GUF1 variants -> impaired mitochondrial translation elongation fidelity -> defective respiratory chain complex assembly -> neuronal energy failure/epileptic encephalopathy), 5 HP-bound phenotypes, AR inheritance bound to HP:0000007, GUF1 genetic block with p.(Ala609Ser) variant detail, CASES_IN_LITERATURE prevalence (4 reported patients), mtEF4 knockout mouse (FAILS_TO_RECAPITULATE the neurological endpoint, substantiated), yeast and C. elegans experimental models, one KNOWLEDGE_GAP and one HUMAN_MODEL_MISMATCH discussion. Phenotypes reported only in OMIM's synopsis or the primary paper's full text (hypotonia, spasticity, absent speech, microcephaly) were deliberately omitted because the cached record carries only the abstract and no exact quote can be validated; recorded in entry notes. No conforms_to declared: mitochondrial_dysfunction (aging-hallmark scope) and complex_iv_assembly_deficiency (requires human COX enzymology, none exists for GUF1 patients) were considered and rejected, reasoning in entry notes. No antiseizure pharmacotherapy curated: neither human report documents a drug response in a GUF1 patient; the 2023 cohort's regimen prose concerns its Dravet patient (named-entity confusion risk). Validation: just validate, validate-terms, count-verified-snippets (35/35), check-folded-hyphens, check-snippet-length, check-title-snippets, check-snippet-grading, check-duplicate-keys, check-entity-refs, check-causal-targets, check-qualifier-terms, check-enum-values, and the authoritative validate-disorders all PASS. Branch fast-forwarded to origin/main before final validation to clear stale-base title-snippet noise from IgG4-Related_Disease.
Overview. Developmental and epileptic encephalopathy 40 (DEE40) is an ultra-rare autosomal recessive mitochondrial-translation disorder caused by biallelic variants in GUF1 (GTP-binding elongation factor GUF1, chromosome 4p12). It presents as West syndrome: refractory infantile spasms beginning in the first 6 months of life with hypsarrhythmia on EEG, followed by developmental stagnation/regression and severe, lifelong neurologic impairment. It is the only human disease so far attributed to GUF1, the human homolog of bacterial elongation factor 4 (EF4/LepA), a quality-control back-translocase of the mitochondrial ribosome. The disease was delineated by Alfaiz et al. (2016) in three affected siblings of a consanguineous family (PMID:26486472).
Identifiers.
| Resource | Identifier |
|---|---|
| OMIM (phenotype) | #617065 (DEE40; formerly EIEE40) |
| OMIM (gene) | *617064 (GUF1) |
| MONDO | MONDO:0014895 — "developmental and epileptic encephalopathy, 40" (verified in the local MONDO cache) |
| Gene | GUF1, HGNC:25799 (hgnc:25799 in dismech convention), NCBI Gene 60558, chromosome 4p12 |
| Orphanet | No dedicated ORPHA code; Orphanet lists GUF1 as a disease-causing gene for Infantile spasms syndrome (ORPHA:3451) |
| ICD-10 / ICD-11 | Category-level only: G40.4 (other generalized epilepsy and epileptic syndromes) / 8A62 (developmental and epileptic encephalopathies) |
| ClinVar (founder variant) | RCV000239484 (GUF1 c.1825G>T, p.Ala609Ser) |
Synonyms: EIEE40 (early infantile epileptic encephalopathy-40), GUF1-related epileptic encephalopathy, GUF1-related West syndrome.
Data provenance. All clinical information derives from aggregated disease-level resources (OMIM, Orphanet, PanelApp, GenCC) and case-level primary literature — principally one deeply phenotyped sibship (PMID:26486472) plus one additional GUF1-positive patient in a Turkish targeted-NGS cohort (PMID:37820178). No EHR-derived or registry data exist.
Gene-disease validity status (important caveat). The evidence base remains thin: Genomics England PanelApp rates GUF1 AMBER on the "Early onset or syndromic epilepsy" panel (panel 402), and GenCC classifications are "Limited"/"Supportive" (HGNC:25799). A diagnostic-grade (green) rating requires ≥3 unrelated families or 2 families plus convincing functional data; DEE40 currently rests on one family with functional support plus isolated panel-cohort hits.
Primary cause. Homozygous missense variant in GUF1. In the index family, exome sequencing of a consanguineous family (reported by OMIM as of Algerian origin) with three affected siblings identified a homozygous c.1825G>T / p.(Ala609Ser) transversion in exon 15, segregating with disease. Direct quote (PMID:26486472):
"We identified a homozygous variant (c.1825G>T/p.(Ala609Ser)) in the GUF1 gene in the three affected siblings."
"The variant identified in the WS family changes an alanine residue conserved in all eukaryotic organisms and positioned within the tRNA-binding moiety of this nuclear genome-encoded mitochondrial translational elongation factor."
Risk factors. - Genetic: biallelic GUF1 variants; heterozygous carriers are unaffected (autosomal recessive). - Consanguinity is the dominant epidemiologic risk factor — the index family was consanguineous, and homozygosity for an ultra-rare allele is the expected mechanism of recurrence. - Environmental risk/protective factors: none identified; no gene-environment interaction data exist (CTD has no curated GUF1 disease-chemical interactions relevant to this phenotype). A biologically plausible but unproven consideration: GUF1/EF4 function is most critical under cellular stress (temperature, nutrient limitation, ionic stress) in all model systems (PMID:18442968; PMID:24837196), suggesting physiologic stressors could modulate expressivity — this is inference, not observation.
Protective factors. None reported (no protective variants, modifier alleles, or environmental factors documented).
All frequencies below refer to the 3 reported sibs plus OMIM's clinical synopsis; treat "3/3" as the effective denominator.
| Phenotype | Type | Onset | Severity/Course | Frequency | Suggested HPO |
|---|---|---|---|---|---|
| Infantile spasms (epileptic spasms) | Clinical sign | < 6 months | Refractory to treatment | All reported | HP:0012469 (Infantile spasms) |
| Hypsarrhythmia | EEG/laboratory abnormality | Infancy | Pathognomonic of West syndrome | All reported | HP:0002521 (Hypsarrhythmia) |
| Developmental regression / stagnation | Behavioral/developmental | After seizure onset | Severe, non-recovering | All reported | HP:0002376 (Developmental regression) |
| Profound intellectual disability | Cognitive | Established by childhood | Profound | All reported | HP:0002187 (Profound intellectual disability) |
| Absent language | Behavioral | — | Persistent | All reported | HP:0001344 (Absent speech) |
| Axial hypotonia | Clinical sign | Infancy | — | Reported | HP:0008936 (Axial hypotonia) |
| Peripheral spasticity | Clinical sign | Infancy onward | — | Reported | HP:0001257 (Spasticity) |
| Poor/limited eye contact | Behavioral | Infancy | — | Reported | HP:0000817 (Reduced eye contact) |
| Poor feeding | Symptom | Infancy | — | Reported | HP:0011968 (Feeding difficulties) |
| Poor fine motor skills | Clinical sign | Childhood | — | Reported | HP:0007010 (Poor fine motor coordination) |
Key phenotype description (OMIM #617065 clinical summary): DEE40 is "characterized by the onset of refractory infantile spasms within the first 6 months of life"; infants "may have normal or mildly delayed development before the onset of seizures, but thereafter show developmental stagnation and severe neurologic impairment"; EEG "typically shows hypsarrhythmia, consistent with a clinical diagnosis of West syndrome."
The defining West syndrome triad, quoted exactly from the index paper (PMID:26486472):
"West syndrome (WS), defined by the triad of infantile spasms, pathognomonic hypsarrhythmia and developmental regression, is a rare epileptic disease affecting about 1:3500 live births."
Quality-of-life impact. No formal QoL instruments (EQ-5D, PedsQL) have been applied to DEE40. By analogy with cohort data on epileptic encephalopathies generally, dependency is severe: in the Turkish DEE cohort containing the fourth GUF1 patient, patients with severe intellectual disability were "completely dependent on the help of their relatives in their daily life activities" (PMID:37820178).
Causal gene. GUF1 (HGNC:25799; NCBI Gene 60558; OMIM 617064; 4p12). Encodes a nuclear-encoded, mitochondrially targeted translation elongation factor — the human ortholog of E. coli LepA/EF4 and S. cerevisiae* Guf1. UniProt: GUF1_HUMAN (Q8N442).
Pathogenic variants. - c.1825G>T, p.(Ala609Ser) — exon 15, homozygous, germline; missense; the sole published segregating allele (PMID:26486472). ClinVar RCV000239484. Ala609 is "conserved in all eukaryotic organisms and positioned within the tRNA-binding moiety" of the protein (PMID:26486472). Functional class: neither clean loss nor gain — a conditional/context-dependent hypomorph; yeast complementation showed "the activity of GUF1(A609S) is modified in suboptimal environments" (PMID:26486472). - One additional GUF1-mutated patient was identified by a 54-gene targeted epilepsy panel in a Turkish DEE cohort (1 GUF1 hit among 48 genetically solved of 198 patients; variant details not given in the paper) (PMID:37820178). - Allele frequency: the A609S allele is absent/ultra-rare in population databases (per the original report); no recurrent or founder alleles are otherwise documented in gnomAD at appreciable frequency. - All variants reported to date are germline; there is no somatic disease association for this phenotype (mtEF4 overexpression has a separate somatic-cancer literature — see §6).
Modifier genes, epigenetics, chromosomal abnormalities. None identified. No DNA-methylation or chromatin data specific to DEE40 exist; no structural variants of GUF1 have been reported as causal.
No environmental, lifestyle, or infectious contributors are documented for DEE40; it is a fully penetrant (within the one reported family) Mendelian mitochondrial disorder. The only environment-adjacent observation is mechanistic: GUF1/EF4 function becomes rate-limiting under stress conditions (low temperature, nutrient limitation, altered Mg²⁺) in yeast, worm, and bacterial systems — see §6.
Branch (tissue-specificity / compensation). In mouse, somatic tissues buffer mtEF4 loss: "Somatic tissues overcame this defect by activating mechanistic (mammalian) target of rapamycin (mTOR), thereby increasing rates of cytoplasmic translation to match rates of mitochondrial translation," whereas cells that developmentally downregulate mTOR (spermatogenic cells) undergo "cell-cycle arrest and apoptosis" (PMID:27065197). Why the human brain is vulnerable while the mouse brain is spared is an open question — plausibly the human A609S allele behaves differently from a null, and/or neuronal mTOR-mediated compensation is insufficient in the developing human cortex. This is an explicit human-model mismatch (see §15).
CASES_IN_LITERATURE.There is no disease-specific or mechanism-directed therapy. Management follows standard-of-care for infantile spasms/West syndrome and supportive care for severe DEE.
| Intervention | Notes | Suggested NCIT |
|---|---|---|
| Hormonal therapy (ACTH, high-dose oral corticosteroids) | First-line for infantile spasms per consensus (US consensus report; UKISS) | NCIT:C15986 Pharmacotherapy (+ agent terms) |
| Vigabatrin | First-line alternative (first choice in TSC; used broadly in spasms) | NCIT:C15986 Pharmacotherapy; agent CHEBI:63638 (vigabatrin) |
| Antiseizure medications (valproate, benzodiazepines, topiramate, levetiracetam, etc.) | Seizures reported refractory in DEE40 | NCIT:C15986 Pharmacotherapy |
| Ketogenic diet | Used in refractory spasms; in one cohort, ketogenic diet/prednisone/ACTH exposure was associated with lower LGS evolution risk (PMID:37820178) | NCIT:C15447 Dietary Intervention |
| Supportive/rehabilitative care: physiotherapy, feeding support, spasticity management | Standard for profound DEE | NCIT:C15747 Supportive Care; NCIT:C15302 Physical Therapy |
| Genetic counseling for the family | AR recurrence risk 25% | NCIT:C15240 Genetic Counseling |
No naturally occurring GUF1-deficiency disease is documented in companion animals or wildlife (no OMIA entry). The gene is, however, among the most anciently conserved translation factors, and the comparative biology is unusually rich:
| Model | Type | Recapitulation of DEE40 | Key limitation |
|---|---|---|---|
| Yeast guf1Δ + GUF1(A609S) complementation | In vitro / unicellular | Variant-level functional model: "the activity of GUF1(A609S) is modified in suboptimal environments" (PMID:26486472) | No nervous system; phenotype only under stress conditions |
| Mouse Guf1/mtEF4 KO (global and germline-specific) | Mammalian knockout | Fails to recapitulate the human neurologic disease — phenotype confined to spermatogenesis/male infertility; brain and heart grossly normal (PMID:27065197) | Somatic mTOR-mediated compensation masks neuro phenotype; null allele vs. human missense; classic candidate for a dismech FAILS_TO_RECAPITULATE/HUMAN_MODEL_MISMATCH annotation |
| C. elegans mtef4 deletion | Invertebrate | Partial mechanism-level recapitulation: complex IV supercomplex assembly defect, temperature-dependent (PMID:24837196) | No seizure/encephalopathy correlate; strongest at 15 °C |
| Human cell-line mtEF4 KO/knockdown | In vitro | Mechanism-level: "Knockout of mtEF4 induced respiratory chain complex defects and apoptosis" (PMID:29572227) | Cancer-line context; not neuronal |
Resources: MGI (Guf1), WormBase, SGD (GUF1/YLR289W), IMPC. Applications: the yeast complementation assay is the established readout for classifying new GUF1 missense variants — directly relevant to resolving future VUS. Unmet model need: no neuronal or brain-conditional model (e.g., patient iPSC-derived neurons, knock-in A609S mouse) exists; this is the experiment that would close the largest gap in the causal chain (step 6, §6).
Sources: - OMIM #617065 — Developmental and Epileptic Encephalopathy 40 - OMIM *617064 — GTP-Binding Elongation Factor GUF1 - Alfaiz et al. 2016, Eur J Hum Genet — West syndrome caused by homozygous GUF1 variant (PMID:26486472) - PMC version of Alfaiz et al. 2016 - Bauerschmitt et al. 2008, J Biol Chem — yeast Guf1 promotes mitochondrial protein synthesis under suboptimal conditions (PMID:18442968) - Gao et al. 2016, Nat Struct Mol Biol — mtEF4 knockout mouse, spermatogenesis (PMID:27065197) - Yang et al. 2014, BBA — C. elegans mtEF4 and respiratory dysfunction (PMID:24837196) - Zhu et al. 2018, Cancer Res — human EF4 as mitochondrial translation switch (PMID:29572227) - Li & Qin 2018, Free Radic Res — mtEF4, OXPHOS complexes and ROS (PMID:30693836) - Bariş et al. 2023, Rev Assoc Med Bras — targeted NGS in pediatric DEE, incl. 1 GUF1 patient (PMID:37820178) - Genomics England PanelApp — GUF1, Early onset or syndromic epilepsy panel (AMBER) - Genomics England PanelApp — GUF1, Mitochondrial disorders panel - GenCC — GUF1 (HGNC:25799) classifications - ClinGen — GUF1 curation results - NIH Genetic Testing Registry — GUF1 (Gene 60558) - Orphanet — GUF1 gene page (Infantile spasms syndrome, ORPHA:3451) - MalaCards — Developmental and Epileptic Encephalopathy 40 - GeneCards — GUF1
Checked with linkml-reference-validator 0.2.1.
| Outcome | Count |
|---|---|
| References checked | 13 |
| Resolved | 13 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| Quoted claims checked | 14 |
| Quoted claims found in source | 14 |
| Quoted claims not found in source | 0 |
| References weighed for topical relevance | 13 |
| On topic | 4 |
| Off topic | 0 |
All extracted references resolved successfully.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 38 |
| Resolved | 36 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 2 |
| Terms whose name was checked | 20 |
| Terms named correctly | 14 |
| Terms named as a different term | 2 |
| Terms whose name is worth a second look | 4 |
These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:
GO:0003924 (1 mention) - the report calls it "Protein dysfunction: GUF1 is a ribosome-dependent GTPase"; GO calls it GTPase activity**CL:0000540 (2 mentions) - the report calls it "Tissue/cell level: neurons"; CL calls it neuron**The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:
UBERON:0000955 (1 mention) - the report calls it "Organ level: brain"; UBERON calls it brain**, and lists "the brain" among its other namesGO:0005739 (1 mention) - the report calls it "Subcellular level: mitochondrion"; GO calls it mitochondrion**NCBITaxon:6239 (1 mention) - the report calls it "C. elegans"; NCBITaxon calls it Caenorhabditis elegans, and lists "Rhabditis elegans" among its other namesNCBITaxon:4932 (1 mention) - the report calls it "S. cerevisiae"; NCBITaxon calls it Saccharomyces cerevisiae, and lists "Mycoderma cerevisiae" among its other namesTerms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA.